US FDA Inspects Cadila Healthcare’s Pharmaceutical Technology Center at Ahmedabad

Cadila Healthcare announced that the US FDA inspected the Pharmaceutical Technology Center (PTC), the company’s state-of-the-art R&D facility located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral, parenteral, pulmonary, oncology, ointment & creams and transdermal, from 18 March to 22 March 2019. At the end of the inspection, no observations (483) have been issued. – Business Standard